Lakkaraju Roop Kalyan 4
4 · BIO-RAD LABORATORIES, INC. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIO.B
Lakkaraju Roop Kalyan
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Bio-Rad A Common Stock
2025-09-06+1,535→ 2,393.659 total - Exercise/Conversion
Restricted Stock Units
2025-09-06−1,535→ 4,608 totalExercise: $0.00→ Bio-Rad A Common Stock (1,535 underlying) - Tax Payment
Bio-Rad A Common Stock
2025-09-06$295.43/sh−550$162,487→ 1,843.659 total - Award
Restricted Stock Units
2025-09-05+5,480→ 5,480 totalExercise: $0.00→ Bio-Rad A Common Stock (5,480 underlying)
Footnotes (4)
- [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
- [F2]Includes 13.2750 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2025.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- [F4]The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.